Medication atypical

Risperidone was launched in China in 1997. Following that, other atypical medication including olanzapine and quetiapine were introduced in the market in 1999 and 2000, respectively. These were followed by the development of generic arip-iprazole and ziprasadone in 2005 and 2006, respectively. Brand-name aripiprazole and ziprasadone will also be launched in 2007 in China. 

Adler LE, Olincy A, Cawthra E, McRae K, Harris J, et al. 2004. The varied effects of atypical medications on P50 auditory... 

NAA in ACC of patients patients on typical psychotics show lower NAA signal than patients on atypical medications Age-corrected NAA correlates significantly with duration of illness... 

J, NAA/Cho in left inferior FL of patients verbal memory deficits correlated with NAA/PCr ratio J, Inositol/Cr in left TL of patients J, NAA/Cr in left thalamus of patients j1 NAA in left FL and J, Cho in left BG of patients on atypical medications l NAA in thalamus of patients left thalamic NAA level negatively correlated with illness duration no other metabolite differences found... 

Drug interactions with this new classification of atypical medications are multiple. Therefore, it is essential to take a thorough medication history. Clozapine (Clozaril), risperidone (Risperdal), sertindole (Serlect), olanzapine (Zyprexa), and quentiapine (Seroquel) are fairly new and a long history of use in the practice setting has not been established. There are many side effects and possible interactions that have not been discovered yet. It is imperative that potential drug interactions be recorded and monitored closely for changes in efficacy, toxicity, and if applicable, drug concentration (Lam, 2000). 

George TP, Ziedonis DM, Feingold A, et al Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 157 1835-1842, 2000... 

Changes in perceived physical and mental health status of a schizophrenia patient population following initiation of a conventional or an atypical antipsychotic medication. Poster presented at the American Psychiatric Association Annual Meeting, Toronto, June 1998. 

Typical and atypical antipsychotic medications (D2-receptor antagonists)... 

Many patients with GERD relapse if medication is withdrawn, and long-term maintenance treatment is required in such patients.1 Candidates for maintenance therapy include patients whose symptoms return once therapy is discontinued or decreased, patients with complications such as Barrett s esophagus or strictures, and perhaps patients with atypical symptoms. 

Older individuals have decreased host defense mechanisms such as slowed gastric emptying and decreased saliva production. They may present with atypical symptoms such as chest pain, asthma, hoarseness, coughing, wheezing, or poor dentition. These patients often do not seek medical attention because they believe their symptoms are part of the normal aging process. 

Each antidepressant has a response rate of approximately 60% to 80%, and no antidepressant medication or class has been reliably shown to be more efficacious than another 22 MAOIs may be the most effective therapy for atypical depression, but MAOI use continues to wane because of problematic adverse effects, dietary restrictions, and possibility of fatal drug interactions.22,28 There is some evidence that dual-action antidepressants, such as TCAs and SNRIs, may be more effective for inpatients with severe depression than are the single-action drugs such as SSRIs,22,28 but the more general assertion that multiple mechanisms of action confer efficacy advantages is quite controversial.33... 

First, initiate and/or optimize mood-stabilizing medication lithium3 or valproate3 or atypical antipsychotic (e.g., olanzapine, quetiapine, risperidone)... 

Bailey, R. K. (2003). Atypical psychotropic medications and their adverse effects a review for the African-American primary care physician. /. Natl. Med. Assoc., 95, 37—-14. 

What are the expected differences in side-effect profiles between ethnic groups, in particular with selective serotonic re-uptake inhibitors and atypical antipsychotics Can the morbidity of medication side effects be reduced, hence increasing treatment compliance and effectiveness ... 

Non-motor signs of the disorder are also treatable with symptomatic medications. The frequent mood disorder can be treated with standard antidepressants, including tricyclics (such as amitryptiline) or serotonin reuptake inhibitors (SSRIs, such as fluoxetine or sertraline). This treatment is not without risks in these patients, as it may trigger manic episodes or may even precipitate suicide. Anxiety responds to benzodiazepines, as well as to effective treatment of depression. Long-acting benzodiazepines are favored over short-acting ones because of the lesser abuse potential. Some of the behavioral abnormalities may respond to treatment with the neuroleptics as well. The use of atypical neuroleptics, such as clozapine is preferred over the typical neuroleptics as they may help to control dyskinesias with relatively few extrapyramidal side-effects (Ch. 54). 

Nevertheless, some atypical antipsychotic drugs, such as clozapine and olanzapine, have been linked to substantial weight gain, hyperlipidemia and type II diabetes, a new range of medically serious side-effects. 

Consider atypical antipsychotic medication if disruptive hallucinosis or psychosis persists. 

---